rubella
viru
rv
virion
contain
two
envelop
glycoprotein
el
remov
hydrophob
region
carboxyl
termini
genet
engin
caus
secret
rather
maintain
cell
membran
transfect
co
cell
truncat
secret
absenc
el
wherea
el
lack
transmembran
domain
requir
coexpress
export
cell
secret
found
contain
olink
nlink
complex
glycan
wherea
secret
el
retain
viru
neutral
hemagglutin
epitop
suggest
possibl
use
solubl
rv
antigen
subunit
vaccin
serodiagnost
purpos
stabl
chines
hamster
ovari
cell
line
secret
rv
el
construct
larg
scale
prepar
recombin
el
human
pathogen
sinc
first
trimest
infect
frequent
result
variou
birth
defect
collect
known
congenit
rubella
syndrom
cooper
buimovici
klein
current
vaccin
live
attenu
viru
prophylact
measur
choic
howev
complic
polyarthralgia
arthriti
result
although
rare
immun
rv
virion
consist
singlestrand
polyadenyl
rna
encapsid
capsid
protein
turn
enclos
envelop
consist
two
viru
encod
glycoprotein
el
okerblom
et
al
structur
protein
rv
initi
translat
precursor
polyprotein
order
nh
subgenom
mrna
okerblom
synthesi
polyprotein
cleav
yield
two
membran
glycoprotein
el
kda
kda
basic
kda
capsid
c
protein
okerblom
okerblom
et
al
el
compris
spike
complex
thought
exist
heterodim
waxham
wolinski
hobman
et
al
insert
glycoprotein
el
endoplasm
reticulum
er
mediat
two
independ
function
signal
peptid
cleav
host
signal
peptidas
hobman
et
al
hobman
gillam
rv
glycoprotein
form
heterodim
er
transport
retain
golgi
complex
hobman
et
al
baron
forsel
transfect
co
cell
small
quantiti
detect
cell
surfac
presenc
absenc
el
hobman
gillam
hobman
et
al
rv
virion
shown
contain
sialyl
olink
carbohydr
lundstrom
et
al
sanchez
frey
sinc
antibodi
viral
neutral
vn
hemagglutin
inhibit
hai
activ
direct
el
waxham
wolinski
green
dorsett
suggest
el
major
target
bcell
respons
therefor
candid
subunit
vaccin
would
contain
el
immunogen
form
biolog
role
well
defin
although
report
possess
strainspecif
epitop
dorsett
et
al
possibl
least
one
neutral
domain
green
dorsett
rv
el
rich
cystein
residu
contain
intramolecular
disulfid
bridg
import
maintain
proper
protein
fold
qiu
et
al
qiu
et
al
rv
glycoprotein
purifi
virion
show
greatli
reduc
antigen
compar
intact
viru
loo
et
al
presum
due
disrupt
conform
el
isol
bioengin
el
express
escherichiu
coli
low
immunogen
compar
nativ
el
elicit
product
antibodi
although
abl
induc
low
level
vn
antibodi
terri
et
al
express
solubl
form
rv
el
protein
cultur
cell
would
facilit
isol
antigen
el
protein
biochem
studi
well
develop
serodiagnost
assay
subunit
vaccin
rv
studi
investig
possibl
express
solubl
form
rv
el
protein
cultur
cell
use
largescal
prepar
immunogen
el
remov
put
transmembran
domain
region
encod
ctermin
amino
acid
delet
cut
plasmid
xbai
follow
partial
digest
ncoi
xbai
ncoi
termini
made
blunt
dna
polymeras
ligat
use
dna
ligas
fig
lf
creat
replac
fragment
fig
le
fragment
elatm
fig
lb
result
plasmid
atm
co
cell
transfect
recombin
plasmid
label
methionin
rvspecif
protein
immunoprecipit
previous
describ
hobman
gillam
immun
complex
wash
rv
antigen
elut
mm
sodium
citrat
ph
sd
mm
phenylmethylsulfonyl
fluorid
min
analyz
sdspage
laemmli
immunoprecipit
digest
endoglycosidas
h
nglycosidas
f
endoglycosidas
f
neuraminidas
describ
supplier
boehring
mannheim
use
lipofectin
gibco
cotransfect
dihydrofol
reductas
defici
dhfr
chines
hamster
ovari
cell
urlaub
chasin
atm
plasmid
simonsen
levinson
latter
plasmid
contain
mous
dhfr
gene
control
earli
promot
use
select
marker
clone
select
abil
grow
dialyz
fetal
bovin
serum
contain
nucleosid
indic
express
transfect
dhfr
gene
select
clone
expand
screen
presenc
rv
antigen
indirect
iunofluorscen
hobman
et
al
secret
rv
el
radioimmunopreipit
sequenc
analysi
vitro
transloc
experi
suggest
rv
el
type
membran
glycoprotein
anchor
lipid
bilay
ctermin
hydrophob
domain
clark
et
al
hobman
et
al
remov
domain
tm
convert
solubl
protein
codon
acid
peptid
encod
transmembran
anchor
el
locat
residu
cterminu
protein
fig
la
delet
use
oligonucleotidedirect
mutagenesi
kunkel
result
elatm
cdna
clone
ecori
site
eukaryot
express
vector
andersson
et
al
transfect
co
cell
use
deaedextran
pgml
previous
describ
hobman
et
al
forti
hour
posttransfect
cell
pulselabel
zi
methionin
min
chase
indic
time
medium
excess
unlabel
methionin
cell
lyse
immunoprecipit
rv
protein
prepar
use
human
antirv
serum
describ
hobman
et
al
sampl
subject
sdspage
polyacrylamid
gel
follow
autoradiographi
elatm
glycoprotein
detect
medium
transfect
cell
chase
period
evid
nlink
sugar
process
fig
elatm
glycoprotein
remain
complet
sensit
endo
h
even
chase
period
shown
suggest
transport
arrest
medial
golgi
apparatu
moreov
indirect
immunofluoresc
indic
elatm
protein
present
larg
rough
er
shown
contrast
wild
type
el
accumul
postrough
er
pregolgi
compart
hobman
et
al
rv
el
may
contain
signal
block
transport
describ
limit
number
membran
glycoprotein
colley
et
al
jackson
et
al
macham
rose
nilsson
et
al
domain
known
date
caus
retent
membran
protein
er
golgi
apparatu
locat
within
membranespan
peptid
immedi
proxim
determin
case
el
made
construct
elabamhi
fig
id
encod
el
protein
lack
ctermin
amino
acid
includ
put
transmembran
region
flank
lumin
cytoplasm
domain
co
cell
transfect
pcmvselabamhi
label
methionin
follow
chase
period
none
ela
bamhi
glycoprotein
could
detect
medium
radiolabel
transfect
cell
fig
consist
observ
delet
mutant
protein
distribut
cytoplasm
reticular
pattern
characterist
er
shown
unknown
reason
consist
observ
elabamhi
glycoprotein
express
lower
level
per
cell
elatm
wild
type
el
protein
shown
one
problem
associ
identifi
retent
signal
delet
analysi
often
result
protein
fold
properli
retain
er
order
address
question
whether
cytoplasm
tail
el
prevent
elatm
protein
secret
creat
eltmct
fig
lc
codon
glu
immedi
preced
acid
transmembran
domain
el
chang
gag
tag
translat
anchor
cytoplasm
domain
occur
found
eltmctglycoprotein
behav
similarli
elatm
elabamhi
protein
remain
cellassoci
transfect
co
cell
detect
medium
three
hour
chase
period
fig
determin
truncat
glycoprotein
could
secret
co
cell
truncat
cdna
fig
lg
construct
use
conveni
restrict
site
cdna
cdna
subclon
transfect
co
cell
use
biosynthet
label
experi
found
glycoprotein
kda
secret
timedepend
manner
fig
contain
endo
hresist
sugar
fig
medium
lane
h
contrast
kda
intracellular
form
contain
mainli
endo
hsensit
sugar
fig
cell
lane
h
digest
enzym
mixtur
nglycosidas
f
endoglycosidas
f
hydrolyz
nlink
glycan
high
mannos
complex
type
reduc
size
intracellular
kda
secret
kda
kda
respect
indic
presenc
high
mannos
complex
type
nlink
sugar
protein
fig
lane
nf
investig
possibl
higher
appar
molecular
weight
observ
secret
due
presenc
olink
sugar
immunoprecipit
digest
neuraminidas
treatment
mobil
intracellular
affect
treatment
fig
cell
wherea
lower
molecular
weight
band
observ
secret
treatment
neuraminidas
fig
medium
demonstr
presenc
olink
glycan
secret
form
slight
decreas
appar
molecular
weight
secret
neuraminidas
treatment
indic
oligosaccharid
contain
termin
sialic
acid
fig
medium
lane
ne
previous
demonstr
coexpress
result
transport
limit
amount
el
surfac
co
cell
obman
et
al
determin
el
atm
protein
would
secret
coexpress
cdna
encod
rv
gene
el
atm
protein
creat
replac
fragment
fig
le
hobman
gillam
fragment
fig
lb
result
plasmid
fig
follow
transfect
plasmid
co
cell
kda
solubl
el
glycoprotein
could
detect
medium
min
chase
fig
suggest
acid
peptid
delet
el
inde
membranespan
region
protein
rv
also
present
medium
cell
although
much
lower
amount
fig
present
unclear
whether
proteolyt
cleavag
occur
releas
medium
altern
interact
elatm
may
alter
conform
stabl
membran
contrast
el
detect
medium
cell
express
protein
alon
four
hour
chase
although
could
detect
medium
latter
case
fig
lane
arrowhead
order
use
product
solubl
el
subunit
vaccin
diagnost
purpos
better
express
system
transient
transfect
necessari
use
lipofectin
gibco
cotransfect
dhfrchines
hamster
ovari
cell
cho
urlaub
chasm
plasmid
simonsen
levinson
latter
plasmid
contain
mous
dhfr
gene
control
earli
promot
use
select
marker
clone
select
abil
grow
dialyz
fetal
bovin
serum
ie
absenc
nucleosid
indic
express
transfect
dhfr
gene
select
clone
expand
screen
presenc
rv
antigen
indirect
immunofluoresc
secret
rv
el
radioimmunoprecipit
fig
show
result
biosthet
label
experi
one
stabl
elsecret
cell
line
autoradiograph
scan
densitomet
found
one
two
four
hour
chase
respect
total
el
found
medium
fig
judg
heterogen
el
rv
protein
recov
cell
lysat
media
radioimmunoprecipit
human
antirv
serum
antiel
monoclon
vn
lane
immunoprecipit
split
two
part
incub
without
mu
endo
h
glycosidas
least
h
equal
amount
immunoprecipit
cell
lysat
media
sampl
electrophores
sdspage
label
molecular
weight
standard
kda
includ
refer
viral
neutral
vn
antibodi
hemagglutin
inhibit
hai
antibodi
use
precipit
chase
media
label
cell
identifi
kda
band
precipit
human
antirv
serum
arrow
unknown
band
fig
rv
glycoprotein
express
cho
cell
appear
heavili
glycosyl
express
co
cell
littl
detect
medium
transfect
cho
cell
golgi
process
cho
cell
migrat
heterogen
sdspage
co
cell
consequ
spread
difficult
detect
autoradiographi
therefor
may
much
secret
cho
cell
heterogen
glycosyl
easili
visibl
medium
although
el
secret
four
hour
approxim
cellassoci
el
resist
endo
h
glycosidas
whether
fraction
el
retain
golgi
apparatu
cell
surfac
complex
membraneanchor
determin
addit
anoth
protein
kda
found
coprecipit
el
cultur
medium
elspecif
sinc
recogn
two
monoclon
antibodi
el
arrow
present
serolog
techniqu
whole
rv
target
antigen
detect
antibodi
rv
commonli
use
laboratori
diagnosi
acut
congenit
rubella
infect
determin
rubella
immun
assay
lack
defin
specif
individu
structur
protein
known
rv
antigen
detect
assay
katow
sugiura
observ
antibodi
el
protein
predomin
follow
rv
infect
contrast
antibodi
protein
rel
abund
congenit
rubella
syndrom
form
rv
infect
thu
may
necessari
use
antigen
form
individu
rv
structur
protein
serodiagnost
assay
regard
stabl
cell
line
express
high
level
secret
el
may
prove
conveni
sourc
el
serolog
diagnosi
rv
immun
statu
well
rv
vaccin
develop
studi
convert
normal
membranebound
rv
glycoprotein
el
secret
form
use
transient
express
system
although
normal
present
member
heterodimer
spike
complex
requir
el
transport
cell
surfac
solubl
form
behav
like
previous
describ
secret
form
viral
glycoprotein
geth
sambrook
rose
bergmann
contrast
elatm
protein
retain
intracellularli
express
absenc
fig
secret
elatm
protein
retain
capac
bind
antiel
monoclon
antibodi
vn
properti
fig
demonstr
protein
retain
epitop
expect
import
properti
subunit
vaccin
rv
vn
epitop
el
map
amino
acid
terri
et
al
wolinski
et
al
probabl
region
protein
may
acquir
nativ
tertiari
structur
time
cterminu
elatm
protein
releas
lumen
er
whether
elatm
protein
elicit
product
vn
antibodi
remain
determin
